What is MapLight Therapeutics, Inc. 's quick ratio?

MapLight Therapeutics, Inc. (MPLT) reported quick ratio of 22.9× in Q1 2026.

What does quick ratio mean?

Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.

MapLight Therapeutics, Inc. MPLT Quick ratio

Quick ratio at other companies

Bristol-Myers SquibbBMY

1.3×+0.1×

Johnson & JohnsonJNJ

0.8×-0.3×

Neurocrine BiosciencesNBIX

2.9×-0.2×

Acadia PharmaceuticalsACAD

3.6×+0.7×

AbbVieABBV

0.7×0.0×

LBR

LB Pharmaceuticals Inc Common StockLBRX

35.7×—

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Market cap$1.39B+100%

Enterprise value$1.34B—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity0×—

Current ratio22.9×—

Where this comes from

Calculated from MapLight Therapeutics, Inc. ’s reported figures.

quick assets/total current liabilities=22.9×

Based on the most recent quarter.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's quick ratio?: MapLight Therapeutics, Inc. (MPLT) reported quick ratio of 22.9× in Q1 2026.
What does quick ratio mean?: Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.